Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Harvard Scientific to present impotence abstract

Jan. 10, 1997

New insights into melanocortin role in obesity

Jan. 9, 1997

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

Jan. 9, 1997

Gene discovery collaboration announced

Jan. 9, 1997

ALRT announces new additions to the product pipeline

Jan. 9, 1997

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

Jan. 9, 1997

Celtrix completes phase I studies of SomatoKine

Jan. 8, 1997

Leptin triggers reproductive function

Jan. 8, 1997

Bimoclomol progresses in trials

Jan. 8, 1997

Lilly synthesizes antiobesity proteins

Jan. 8, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...